{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T13:47:10Z","timestamp":1764510430001},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.beha.2012.01.003","type":"journal-article","created":{"date-parts":[[2012,2,8]],"date-time":"2012-02-08T15:46:45Z","timestamp":1328716005000},"page":"3-12","source":"Crossref","is-referenced-by-count":15,"title":["New insights into the biology of molecular subtypes of diffuse large B-cell lymphoma and Burkitt lymphoma"],"prefix":"10.1016","volume":"25","author":[{"given":"Mareike","family":"Frick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"D\u00f6rken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.beha.2012.01.003_bib1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.beha.2012.01.003_bib2","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2012.01.003_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm0102-68","article-title":"Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning","volume":"8","author":"Shipp","year":"2002","journal-title":"Nat Med"},{"issue":"22","key":"10.1016\/j.beha.2012.01.003_bib4","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.beha.2012.01.003_bib5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"issue":"12","key":"10.1016\/j.beha.2012.01.003_bib6","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.beha.2012.01.003_bib7","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa055759","article-title":"Molecular diagnosis of Burkitt\u2019s lymphoma","volume":"354","author":"Dave","year":"2006","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.beha.2012.01.003_bib8","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beha.2012.01.003_bib9","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow","year":"2008"},{"issue":"5","key":"10.1016\/j.beha.2012.01.003_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00001622-200109000-00003","article-title":"Diffuse large cell lymphoma","volume":"13","author":"Coiffier","year":"2001","journal-title":"Curr Opin Oncol"},{"issue":"5","key":"10.1016\/j.beha.2012.01.003_bib11","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood"},{"issue":"5312","key":"10.1016\/j.beha.2012.01.003_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1126\/science.276.5312.589","article-title":"Control of inflammation, cytokine expression, and germinal center formation by BCL-6","volume":"276","author":"Dent","year":"1997","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.beha.2012.01.003_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng0697-161","article-title":"The BCL-6 proto-oncogene controls germinal-centre formation and Th2- type inflammation","volume":"16","author":"Ye","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.beha.2012.01.003_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-2776(10)05007-8","article-title":"Dalla-Favera R BCL6: master regulator of the germinal center reaction and key oncogene in B cell lymphomagenesis","volume":"105","author":"Basso","year":"2010","journal-title":"Adv Immunol"},{"issue":"2","key":"10.1016\/j.beha.2012.01.003_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1074-7613(00)00020-0","article-title":"BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control","volume":"13","author":"Shaffer","year":"2000","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.beha.2012.01.003_bib16","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/nm1134","article-title":"Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells","volume":"10","author":"Polo","year":"2004","journal-title":"Nat Med"},{"issue":"7017","key":"10.1016\/j.beha.2012.01.003_bib17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nature03147","article-title":"The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells","volume":"432","author":"Phan","year":"2004","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.beha.2012.01.003_bib18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/ni1245","article-title":"BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells","volume":"6","author":"Phan","year":"2005","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.beha.2012.01.003_bib19","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/ni1478","article-title":"Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR","volume":"8","author":"Ranuncolo","year":"2007","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.beha.2012.01.003_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.bcmd.2008.02.003","article-title":"Melnick A BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells","volume":"41","author":"Ranuncolo","year":"2008","journal-title":"Blood Cells Mol Dis"},{"issue":"36","key":"10.1016\/j.beha.2012.01.003_bib21","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.beha.2012.01.003_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.pathol.4.110807.092311","article-title":"PTEN and the PI3-kinase pathway in cancer","volume":"4","author":"Chalhoub","year":"2009","journal-title":"Annu Rev Pathol"},{"issue":"3","key":"10.1016\/j.beha.2012.01.003_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.cell.2008.04.013","article-title":"Tenets of PTEN tumor suppression","volume":"133","author":"Salmena","year":"2008","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.beha.2012.01.003_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/ni1575","article-title":"Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes","volume":"9","author":"Xiao","year":"2008","journal-title":"Nat Immunol"},{"issue":"2","key":"10.1016\/j.beha.2012.01.003_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"issue":"7337","key":"10.1016\/j.beha.2012.01.003_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nature09730","article-title":"Inactivating mutations of acetyltransferase genes in B-cell lymphoma","volume":"471","author":"Pasqualucci","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.beha.2012.01.003_bib27","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2005-04-1399","article-title":"Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction","volume":"106","author":"Bea","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beha.2012.01.003_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1084\/jem.20052204","article-title":"Inactivation of the PRDM1\/BLIMP1 gene in diffuse large B cell lymphoma","volume":"203","author":"Pasqualucci","year":"2006","journal-title":"J Exp Med"},{"issue":"10","key":"10.1016\/j.beha.2012.01.003_bib29","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1182\/blood-2005-09-3778","article-title":"Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas","volume":"107","author":"Tam","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2012.01.003_bib30","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1182\/blood-2008-01-136440","article-title":"Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression","volume":"112","author":"Schmidlin","year":"2008","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.beha.2012.01.003_bib31","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1084\/jem.194.12.1861","article-title":"Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells","volume":"194","author":"Davis","year":"2001","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.beha.2012.01.003_bib32","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1182\/blood-2006-07-025809","article-title":"Aberrant NF-kappaB signaling in lymphoma: mechanisms, consequences, and therapeutic implications","volume":"109","author":"Jost","year":"2007","journal-title":"Blood"},{"issue":"7089","key":"10.1016\/j.beha.2012.01.003_bib33","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature04687","article-title":"A loss-of-function RNA interference screen for molecular targets in cancer","volume":"441","author":"Ngo","year":"2006","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.beha.2012.01.003_bib34","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/nri1944","article-title":"The CARMA1 signalosome links the signalling machinery of adaptive and innate immunity in lymphocytes","volume":"6","author":"Rawlings","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"5870","key":"10.1016\/j.beha.2012.01.003_bib35","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1126\/science.1153629","article-title":"Oncogenic CARD11 mutations in human diffuse large B cell lymphoma","volume":"319","author":"Lenz","year":"2008","journal-title":"Science"},{"issue":"7277","key":"10.1016\/j.beha.2012.01.003_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nature08638","article-title":"Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma","volume":"463","author":"Davis","year":"2010","journal-title":"Nature"},{"issue":"7247","key":"10.1016\/j.beha.2012.01.003_bib37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nature07968","article-title":"Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma","volume":"459","author":"Compagno","year":"2009","journal-title":"Nature"},{"issue":"7247","key":"10.1016\/j.beha.2012.01.003_bib38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nature07969","article-title":"Frequent inactivation of A20 in B-cell lymphomas","volume":"459","author":"Kato","year":"2009","journal-title":"Nature"},{"issue":"7332","key":"10.1016\/j.beha.2012.01.003_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nature09671","article-title":"Oncogenically active MYD88 mutations in human lymphoma","volume":"470","author":"Ngo","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.beha.2012.01.003_bib40","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2007-04-087734","article-title":"Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas","volume":"111","author":"Ding","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2012.01.003_bib41","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1182\/blood-2007-09-111948","article-title":"Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma","volume":"111","author":"Lam","year":"2008","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.beha.2012.01.003_bib42","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","article-title":"Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (\"Groupe d\u2019Etude des Lymphomes de l\u2019Adulte\") study","volume":"20","author":"Cazals-Hatem","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"10.1016\/j.beha.2012.01.003_bib43","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.MP.0000032534.81894.B3","article-title":"MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas","volume":"15","author":"Copie-Bergman","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.beha.2012.01.003_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/1078-0432.28.11.1","article-title":"Small molecule inhibitors of IkB-kinase are selectively toxic for subgroups of diffuse large B cell lymphoma defined by gene expression profiling","volume":"11","author":"Lam","year":"2005","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.beha.2012.01.003_bib45","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.beha.2012.01.003_bib46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1182\/blood-2003-10-3545","article-title":"Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma","volume":"104","author":"Guiter","year":"2004","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2012.01.003_bib47","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","article-title":"Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line","volume":"105","author":"Melzner","year":"2005","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.beha.2012.01.003_bib48","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.21485","article-title":"Biallelic deletion within 16p13.13 including SOCS-1 in Karpas1106P mediastinal B-cell lymphoma line is associated with delayed degradation of JAK2 protein","volume":"118","author":"Melzner","year":"2006","journal-title":"Int J Cancer"},{"issue":"7338","key":"10.1016\/j.beha.2012.01.003_bib49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.beha.2012.01.003_bib50","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1182\/blood-2004-02-0405","article-title":"Adult Burkitt leukemia and lymphoma","volume":"104","author":"Blum","year":"2004","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.beha.2012.01.003_bib51","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood.V77.5.1092.1092","article-title":"Epstein-Barr virus infection precedes clonal expansion in Burkitt\u2019s and acquired immunodeficiency syndrome-associated lymphoma","volume":"77","author":"Neri","year":"1991","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.beha.2012.01.003_bib52","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1056\/NEJMra032015","article-title":"Gross A Persistence of the Epstein-Barr virus and the origins of associated lymphomas","volume":"350","author":"Thorley-Lawson","year":"2004","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.beha.2012.01.003_bib53","doi-asserted-by":"crossref","first-page":"7824","DOI":"10.1073\/pnas.79.24.7824","article-title":"Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells","volume":"79","author":"Dalla-Favera","year":"1982","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.beha.2012.01.003_bib54","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/gcc.20009","article-title":"Interphase fluorescence in situ hybridization for detection of 8q24\/MYC breakpoints on routine histologic sections: validation in Burkitt lymphomas from three geographic regions","volume":"40","author":"Haralambieva","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.beha.2012.01.003_bib55","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/PAP.0b013e3182169948","article-title":"Gascoyne RD MYC and aggressive B-cell lymphomas","volume":"18","author":"Slack","year":"2011","journal-title":"Adv Anat Pathol"},{"issue":"8","key":"10.1016\/j.beha.2012.01.003_bib56","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1073\/pnas.85.8.2748","article-title":"Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma","volume":"85","author":"Neri","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.beha.2012.01.003_bib57","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.onc.1202468","article-title":"Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt\u2019s lymphoma","volume":"18","author":"Gerbitz","year":"1999","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.beha.2012.01.003_bib58","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1101\/gad.1067003","article-title":"Genomic targets of the human c-Myc protein","volume":"17","author":"Fernandez","year":"2003","journal-title":"Genes Dev"},{"issue":"12","key":"10.1016\/j.beha.2012.01.003_bib59","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nrc2231","article-title":"Reflecting on 25 years with MYC","volume":"8","author":"Meyer","year":"2008","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.beha.2012.01.003_bib60","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1073\/pnas.88.12.5413","article-title":"p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia","volume":"88","author":"Gaidano","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.beha.2012.01.003_bib61","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.1999.17.5.1558","article-title":"Small noncleaved, non-Burkitt\u2019s (Burkit-Like) lymphoma: cytogenetics predict outcome and reflect clinical presentation","volume":"17","author":"Macpherson","year":"1999","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2012.01.003_bib62","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.leu.2404529","article-title":"Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas","volume":"21","author":"Bertrand","year":"2007","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.beha.2012.01.003_bib63","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.beha.2012.01.003_bib64","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/CCO.0b013e32833ed848","article-title":"Front-line management of diffuse large B cell lymphoma","volume":"22","author":"Cabanillas","year":"2010","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2012.01.003_bib65","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen","volume":"14","author":"Magrath","year":"1996","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.beha.2012.01.003_bib66","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt\u2019s lymphoma: results of United Kingdom Lymphoma Group LY06 study","volume":"13","author":"Mead","year":"2002","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.beha.2012.01.003_bib67","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/cncr.21776","article-title":"Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia","volume":"106","author":"Thomas","year":"2006","journal-title":"Cancer"},{"issue":"7360","key":"10.1016\/j.beha.2012.01.003_bib68","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.beha.2012.01.003_bib69","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.beha.2012.01.003_bib70","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1158\/0008-5472.CAN-10-2525","article-title":"Protein kinase C inhibitor Sotrastaurin selectively inhibits the growth of CD79-mutant diffuse large B-cell lymphomas","volume":"71","author":"Naylor","year":"2011","journal-title":"Cancer Res"},{"issue":"11","key":"10.1016\/j.beha.2012.01.003_bib71","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1084\/jem.20091167","article-title":"Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells","volume":"206","author":"Ferch","year":"2009","journal-title":"J Exp Med"},{"issue":"47","key":"10.1016\/j.beha.2012.01.003_bib72","doi-asserted-by":"crossref","first-page":"19946","DOI":"10.1073\/pnas.0907511106","article-title":"Essential role of MALT1 protease activity in activated B cell-like diffuse large B-cell lymphoma","volume":"106","author":"Hailfinger","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.beha.2012.01.003_bib73","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.1008969108","article-title":"Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells","volume":"108","author":"Kloo","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.beha.2012.01.003_bib74","doi-asserted-by":"crossref","first-page":"680","DOI":"10.2353\/jmoldx.2010.090164","article-title":"A novel method of amplification of FFPET-derived RNA enables accurate disease classification with microarrays","volume":"12","author":"Williams","year":"2010","journal-title":"J Mol Diagn"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692612000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692612000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T12:03:26Z","timestamp":1686744206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692612000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1521692612000047"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2012.01.003","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}